Positron emission tomography (PET) – its potential to provide surrogate markers in ALS

about

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis.Distributed corpus callosum involvement in amyotrophic lateral sclerosis: a deterministic tractography study using q-ball imaging.

P2860

Q38983572-7394110E-7AB7-41D7-A57E-B9DB4D632159 Q48707482-24E781A5-75A9-4948-8C20-F8D96128D101

P2860

Positron emission tomography (PET) – its potential to provide surrogate markers in ALS

Item

http://www.wikidata.org/entity/Q57499035

description

наукова стаття, опублікована в січні 2000

@uk

name

Positron emission tomography (PET) – its potential to provide surrogate markers in ALS

@en

type

Item

label

Positron emission tomography (PET) – its potential to provide surrogate markers in ALS

@en

prefLabel

Positron emission tomography (PET) – its potential to provide surrogate markers in ALS

@en

P1476

Positron emission tomography (PET) – its potential to provide surrogate markers in ALS

@en

P2860

Diffusion tensor MRI assesses corticospinal tract damage in ALS.

Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis.

NERVE FIBRE DEGENERATION IN THE BRAIN IN AMYOTROPHIC LATERAL SCLEROSIS

Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning.

Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review.

Comparing functional (PET) images: the assessment of significant change.

The role of positron emission tomography within the spectrum of medical imaging.

Lowered cerebral glucose utilization in amyotrophic lateral sclerosis.

Cortical areas and the selection of movement: a study with positron emission tomography.

Cerebral glucose utilization in motor neuron disease.

P304

s17-s22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/54-14660820050515665

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin R. Turner

P Nigel Leigh

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

amyotrophic lateral sclerosis

Positron emission tomography (PET) – its potential to provide surrogate markers in ALS

about

P2860

P2860

Positron emission tomography (PET) – its potential to provide surrogate markers in ALS

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P921

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P921